Long-Term Safety and Feasibility of Right Atrial Septal Pacing with Lumenless Leads in Patients with Sick Sinus Syndrome

Peng Jin, Lan Su, Tiantian Chen, Shun Zheng, Zhongping Yang, Hao Zhou, Xiao Chen, Shengjie Wu, Lin Lü, Xi Kathy Zhou, Xue Xia, Weijian HuangCJC 2025 · DOI

TL;DR

This study investigates a new method for atrial pacing in patients with sick sinus syndrome (SSS), a condition causing slow heartbeats. By using lumenless leads (LLLs) placed in the right atrial septum (RASp) instead of the traditional right atrial appendage (RAAp), researchers found it to be a safer and more effective approach, significantly reducing the incidence of atrial fibrillation (AF) and speeding up the implantation procedure.

What Problem Does This Paper Address?

Patients with sick sinus syndrome (SSS) often experience bradycardia (slow heart rate) that requires pacemaker therapy. A common concern with atrial pacing, particularly in the right atrial appendage (RAAp), is an increased risk of developing atrial fibrillation (AF). While right atrial septal pacing (RASp) has shown promise in reducing AF, implanting the necessary atrial septal leads can be technically challenging and time-consuming, limiting its widespread adoption. This paper addresses the need for a safer, more efficient, and equally effective method for atrial pacing in SSS patients, specifically by evaluating the long-term safety and feasibility of using lumenless leads (LLLs) for RASp compared to the standard approach using stylet-driven leads (SDLs) for RAAp.

Methods

The study employed a retrospective, single-center design, analyzing data from 329 consecutive patients with SSS who underwent pacemaker implantation. These patients were divided into two groups: the Right Atrial Septal Pacing (RASp) group, which used lumenless leads (LLLs) with a delivery sheath (n=162), and the Right Atrial Appendage Pacing (RAAp) group, which used conventional stylet-driven leads (SDLs) (n=167).

Key aspects of the methodology included:

  • Implantation Procedure: The RASp group utilized the lumenless SelectSecure lead with a specific delivery sheath, guided by fluoroscopy and atrial wave mapping. The RAAp group used conventional SDLs.
  • Data Collection: Preoperative data included ECGs, echocardiography, and Holter monitoring to assess AF history. Postoperative data focused on implantation success rates, procedural and lead implantation times, pacing parameters (sensing, threshold, impedance), P-wave characteristics (duration and dispersion), and AF events.
  • AF Definition: AF events were defined by pacemaker recordings with an atrial rate of >350 beats per minute lasting >6 seconds, with manual review to confirm. New-onset AF was defined as AF not present preoperatively.
  • Statistical Analysis: Standard statistical tests (t-tests, chi-square tests) were used to compare groups, with a significance level set at P < 0.05.

Datasets

The study utilized data from patients treated at the First Affiliated Hospital of Wenzhou Medical University. No new datasets or benchmarks were introduced; the study relied on retrospective patient data collected during routine clinical care and follow-up.

Key Insights and Ideas

  • RASp with LLLs is a Game Changer for Efficiency: The most striking finding is the dramatic reduction in lead implantation time for RASp using LLLs (2.5 ± 1.9 minutes) compared to RAAp with SDLs (10.3 ± 2.9 minutes). This suggests a significant procedural advantage.
  • AF Reduction is Clinically Significant: The RASp group showed a significantly lower incidence of both total postoperative AF (6.7% vs. 14.0%) and new-onset AF (1.8% vs. 4.6%). This directly addresses a major clinical concern with atrial pacing.
  • Safety is Comparable: Despite the procedural differences, the long-term safety and feasibility of RASp with LLLs were comparable to the established RAAp method, with no serious complications reported in either group.
  • Pacing Parameters Remain Stable: The study demonstrated that pacing parameters (sensing, threshold, impedance) remained stable over a mean follow-up of 36.4 months for both pacing sites, indicating good long-term lead performance.
  • Potential for Improved Cardiac Function: While not the primary focus, the study noted improvements in cardiac function and echocardiographic parameters post-pacing, suggesting that RASp might contribute to better overall cardiac health.

Key Results

  • Implantation Success: High success rates were observed in both groups: 98.8% for RASp with LLLs and 97.6% for RAAp with SDLs (P > 0.05).
  • Procedural Time: Lead implantation time was significantly shorter in the RASp group (2.5 ± 1.9 min) compared to the RAAp group (10.3 ± 2.9 min) (P < 0.05).
  • Atrial Fibrillation:
    • Total postoperative AF incidence was lower in the RASp group (6.7%) than in the RAAp group (14.0%) (P = 0.001).
  • New-onset AF incidence was also lower in the RASp group (1.8%) compared to the RAAp group (4.6%) (P = 0.047).
  • The risk of new-onset AF occurrence was significantly lower in RASp patients (hazard ratio 0.53; 95% CI 0.35-0.80; P < 0.01).
  • P-wave Characteristics: Paced P-wave duration was significantly shorter during RASp compared to sinus rhythm and RAAp. P-wave dispersion during RASp was also shorter than during sinus rhythm.
  • Lead-Related Complications: No patients experienced lead-related complications such as pocket hematoma, infection, dislodgement, or loss of capture.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Single-Center Study: The study's retrospective nature and single-center design limit generalizability.
  • Univariate Analysis for AF: The analysis did not perform univariate adjustments for all potential factors influencing AF incidence between the groups.
  • Operator Experience: The significantly shorter procedural time for LLLs in the RASp group was attributed, in part, to the operator's extensive experience, suggesting a potential learning curve for new operators.

Future work suggested by the authors includes:

  • Larger, Multicenter Studies: The need for extensive, multicenter, prospective clinical studies to further validate the clinical benefits of RASp.
  • Emerging Interests in BBAp: Further investigation into Bachmann's bundle area pacing (BBAp), which showed promising results in this study, warrants more attention.
  • Comparison with Other Lead Types: While this study focused on LLLs for RASp and SDLs for RAAp, further comparisons with other lead technologies could be beneficial.

Summary updated

Abstract

The long-term safety and feasibility of RASp with LLLs were comparable to those of RAAp patients with SDLs. The RASp reduced the incidence of postoperative AF episodes and new-onset AF. The RASp by delivery sheath implantation is a safe and effective method.
BibTeX
@inproceedings{jin2025long,
  author = {Peng Jin and Lan Su and Tiantian Chen and Shun Zheng and Zhongping Yang and Hao Zhou and Xiao Chen and Shengjie Wu and Lin Lü and Xi Kathy Zhou and Xue Xia and Weijian Huang},
  title = {{Long-Term Safety and Feasibility of Right Atrial Septal Pacing with Lumenless Leads in Patients with Sick Sinus Syndrome}},
  booktitle = {CJC},
  year = {2025},
  doi = {10.1016/j.cjco.2025.06.014},
}
Figure